Detalles de la búsqueda
1.
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer.
Cancer Immunol Immunother
; 72(3): 759-767, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35976415
2.
Whole-genome mapping of APOBEC mutagenesis in metastatic urothelial carcinoma identifies driver hotspot mutations and a novel mutational signature.
Cell Genom
; 4(4): 100528, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38552621
3.
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.
Nat Commun
; 15(1): 1349, 2024 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38355607
4.
Genome-wide aneuploidy detected by mFast-SeqS in circulating cell-free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer.
Mol Oncol
; 16(10): 2086-2097, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35181986
5.
Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8+ T cells.
Clin Cancer Res
; 28(1): 215-226, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34615720
6.
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma.
Eur Urol
; 81(4): 331-336, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35086719
7.
Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes.
J Immunother Cancer
; 8(2)2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32792357
8.
Systematic Review of Immune Checkpoint Inhibition in Urological Cancers.
Eur Urol
; 72(3): 411-423, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28645491
9.
Reply to Yuxuan Song, Caipeng Qin, and Tao Xu's Letter to the Editor re: J. Alberto Nakauma-González, Maud Rijnders, Job van Riet, et al. Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma. Eur Urol 2022;81:331-6.
Eur Urol
; 82(3): e78-e79, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35717359
10.
PD-L1 Antibody Comparison in Urothelial Carcinoma.
Eur Urol
; 75(3): 538-540, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30497882
11.
Reply to Thomas Gevaert, Markus Eckstein, Rodolfo Montironi, and Antonio Lopez-Beltran's Letter to the Editor re: Maud Rijnders, Astrid A.M. van der Veldt, Tahlita C.M. Zuiverloon, et al. PD-L1 Antibody Comparison in Urothelial Carcinoma. Eur Urol 2019;75:538-40.
Eur Urol
; 75(6): e160-e161, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30723047
12.
Reply to Nelson Martinez Merizalde Balarezo, Mark Monroe Rivera, and Romina A. Tejada's Letter to the Editor re: Maud Rijnders, Ronald de Wit, Joost L. Boormans, Martijn P.J. Lolkema, Astrid A.M. van der Veldt. Systematic Review of Immune Checkpoint Inhibition in Urological Cancers. Eur Urol. 2017;72:411-23. Beyond the Survival Rate, Health-related Quality of Life is Important.
Eur Urol
; 73(3): e67-e68, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29100815
Resultados
1 -
12
de 12
1
Próxima >
>>